Deerfield Management’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-311,754
Closed -$3.42M 130
2021
Q4
$3.42M Buy
+311,754
New +$3.57M 0.07% 105

Other funds holding PYXS

Deerfield Management's PYXS Position: Q1 2022 in Review

Deerfield Management sold out of Pyxis Oncology (PYXS) in Q1 2022, closing a stake of 311,754 shares — an estimated $3.42M sold.

Deerfield Management first reported a position in PYXS in Q4 2021 and held it in 1 quarter. The position peaked at $3.42M in Q4 2021. 45 funds tracked by Wall St. Rank hold PYXS as of Q1 2022.

  • Deerfield Management reported no remaining Pyxis Oncology position as of Q1 2022 after selling out during the quarter.
  • Deerfield Management sold 311,754 Pyxis Oncology shares in Q1 2022, an estimated $3.42M.
  • Deerfield Management first reported a position in Pyxis Oncology in Q4 2021 and held it in 1 quarter.
  • Deerfield Management's Pyxis Oncology position peaked at $3.42M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2022.

Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.